Have you heard about our new programme on valproate? It’s called Valproate: the hard conversations, and (as the name suggests) it’s designed to equip you for conversations about the difficult questions this drug poses around adherence, wellbeing and pregnancy.
Patients taking valproate have told us specifically that they want to have these conversations with pharmacy professionals. It makes sense – we are often the most approachable and readily available point of contact for them. That’s why we want to help you help them manage the risks associated with valproate.
We developed this programme in partnership with Epilepsy Action and real valproate patients. It will give you the opportunity to learn more about some of these challenging consultations, so that when you face them in real life, you will be ready.
